NCT05369533View on ClinicalTrials.gov

Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

March 11, 2024

Study Completion Date

March 11, 2024

Conditions
Stroke
Interventions
DEVICE

Telerehabilitation

The telerehabilitation system will deliver rehabilitation treatment sessions via a secured internet-connected computer. TR sessions will be a combination of games, exercises, stroke education, assessments, in addition to videoconferencing with therapists to discuss progress, issues, goals, and changes to the treatment plan.

DRUG

Sinemet Pill

Sinemet 25/100 will be taken 1 hour prior to TR, for the first 18 sessions.

DRUG

Placebo

Placebo will be taken 1 hour prior to TR, for the first 18 sessions.

Trial Locations (1)

90067

California Rehabilitation Institute, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER